• Successful completion of customer projects boosts half-year sales to €266.4 million
• Order intake at €78.7 million in the second quarter, order book at €325.8 million as of June 30, 2025
• Gross profit and EBIT margins for the full year 2025 expected to be lower after forecast adjustment

Garching, Germany, August 7, 2025 – SUSS MicroTec SE, a leading manufacturer of equipment and process solutions for the semiconductor industry, today published its half-yearly financial report for 2025. The financial figures for the first half of the year, which were already communicated in advance in the ad hoc announcement on July 28, 2025, have been confirmed.

SUSS received orders with a total volume of €78.7 million in the second quarter of 2025. The development of order intake differed significantly between the segments: The majority, €65.8 million, was attributable to the Advanced Backend Solutions segment. Demand was particularly strong for coating solutions used in advanced packaging processes. In contrast, order intake in the Photomask Solutions segment amounted to €12.9 million, primarily reflecting the current weak demand from China. In the first half of 2025, order intake totaled €166.8 million, compared to €192.2 million in the same period of the previous year. Due to the accelerated processing of existing customer orders, the order book as of June 30, 2025, decreased to €325.8 million (previous year: €450.0 million).

“After two exceptionally strong years in terms of order intake, our customers are currently cautious on placing orders in view of the uncertain economic conditions and the ongoing commissioning of the delivered tools,” said Burkhardt Frick, CEO of SUSS. “Many customers are placing orders later and ordering different solutions compared to the peak of the first AI waves, when demand for our temporary bonders and debonders was particularly high.”

Sales rose significantly in the first few months, reaching an outstanding €266.4 million (previous year: €192.8 million). In the Advanced Backend Solutions segment, sales rose by 25.1% to €170.1 million (previous year: €136.0 million), and in the Photomask Solutions segment, sales increased by as much as 69.5% to €96.3 million (previous year: €56.8 million). The second quarter contributed sales of €143.2 million (previous year: €99.3 million), making it the second-strongest quarter in the company's history in terms of sales. Dr. Thomas Rohe, COO of SUSS, commented: “In the first half of the year, we demonstrated that SUSS's operational performance has improved continuously in recent years. In view of the declining order book, we are now beginning to leverage the flexibility in our production network and adjust capacity to the order situation.”

At 37.2%, the gross profit margin was below the forecast range and was mainly affected by one-time charges in the Advanced Backend Solutions segment. Start-up costs for the increased production volume of the UV projection scanner in Taiwan and write-downs of inventories from discontinued projects caused the gross profit margin to fall to 35.1% in the first half of the year. By contrast, the gross profit margin in the Photomask Solutions segment was excellent, significantly exceeding the previous year's figure of 34.5% with a gross profit margin of 40.2% in the first half of the year after two strong quarters.

EBIT rose significantly from €30.1 million to €41.9 million. Accordingly, the EBIT margin in the first half of the year was 15.7%, slightly above the previous year's figure of 15.6%.

Outlook

The order book ensures good visibility in the second half of 2025 and already includes tool orders worth around €60 million, which are scheduled for production and delivery in 2026. However, the product mix will change in the second half of the year. "We expect to achieve the sales target we set at the beginning of the year. However, the current weaker demand may lead to selective underutilization of production capacities as early as the end of 2025. This development and a foreseeably less profitable product mix make us more cautious about profitability in the second half of the year," explains Dr. Cornelia Ballwießer, CFO of SUSS. Accordingly, the Management Board confirms the sales target of €470 to €510 million for the financial year 2025. The gross profit margin is expected to range from 37 to 39%. The EBIT margin is expected to be 13 to 15% for the year.

“In the coming months, we will make the best possible use of our flexibility to adapt to the volume of business and increase our cost efficiency. However, in order to secure the base for our future growth, we are sticking to our plans in research and development as well as our strategic structural projects,” says Dr. Cornelia Ballwießer.
 

The half-yearly financial report is available at www.suss.com/en/investor-relations in German and English.

Media contact:
Sven Koepsel
Vice President Investor Relations and Communications
E-Mail: sven.koepsel@suss.com
Tel.: +49 89 32007151

About SUSS
SUSS is a leading supplier of equipment and process solutions for microstructuring in the semiconductor industry and related markets. In close cooperation with research institutes and industry partners SUSS contributes to the advancement of next-generation technologies such as 3D Integration and nanoimprint lithography as well as key processes for MEMS and LED manufacturing. With a global infrastructure for applications and service SUSS supports more than 8,000 installed systems worldwide. SUSS is headquartered in Garching near Munich, Germany. The shares of SUSS MicroTec SE are traded in the Prime Standard of the German Stock Exchange (ISIN DE000A10K0235). For more information, please visit suss.com.

Legal Disclaimer
All statements in this release other than historical facts are forward-looking statements within the meaning of U.S. Private Securities Litigation Reform Act of 1995. Words such as "believe", "expect", "intend", "anticipate", "estimate", "should", "may", "will", "plan" and similar words and terms used in relation to the enterprise are meant to indicate forward-looking statements of this kind. The company accepts no obligation toward the general public to update or correct forward-looking statements. All forward-looking statements are subject to various risks and uncertainties, as a result of which actual events may diverge numerically from expectations. The forward-looking statements reflect the view at the time they were made.